Table 1.
Sample | Yield (mg/g of DW FSPH) | ACE-Inhibition | Protein Content (mg/g of DW FSPH) | Peptide Content (mg/g of DW FSPH) | |
---|---|---|---|---|---|
Percentage | IC50 Value (mg/mL) | ||||
Fr1 < 1 kDa | 206.28 | 45.08 ± 0.66 a | 1.850 ± 0.06 b | 123.15 ± 2.78 a | 43.81 ± 2.27 a |
1 kDa ≤ Fr2 < 3 kDa | 53.72 | 41.93 ± 1.62 a | 2.000 ± 0.06 b | 336.28 ± 4.96 b | 35.91 ± 1.58 a |
Fr3 ≥ 3 kDa | 703.95 | 86.85 ± 1.89 b | 0.500 ± 0.03 a | 474.03 ± 4.44 b | 243.82 ± 2.9 b |
Values are mean ± SD (n = 3). Different superscript letters are significantly different (p < 0.05). IC50 value defined as the concentration which inhibits 50% of the ACE activity (tested concentration = 2 mg/mL). Captopril, used as a positive control for ACE-inhibition, showed an IC50 value of 0.163 ng/mL. DW, dry weight.